The request of the UK government in order to assess the Covid-19 vaccine.
The regulator was formally asked by the UK Government to assess one of the Covid-19 vaccines. That is the Oxford and AstraZeneca jab. The Department of Health said that move marks the first step to get the vaccine approved if it meets the safety, efficacy and quality standards.
Covid-19 vaccine: Matt Hancock about the regulator
It happens a week after the Medicines and Healthcare products Regulatory Agency (MHRA) was formally asked by the Government to assess the Pfizer/BioNTech vaccine.
Matt Hancock, the Health of Secretary, said that the Government are working hard to be in the best possible position to deploy a vaccine as soon as one is approved by the independent regulator the MHRA.
He added: “We have formally asked the regulator to assess the Oxford/AstraZeneca vaccine, to understand the data and determine whether it meets rigorous safety standards.”
AstraZeneca said it will most likely carry out a further global clinical trial to assess the efficacy of the jab. It befalls after a wonder result discovered 90% protection was achieved when people were given a half dose followed by a full dose.
Covid-19 vaccine: about older people
The acknowledged the finding was as an outcome of a dosing error but said it did not require any new trial to block regulatory approval in countries including the UK.
US scientists doubted a lack of detail in the trial results published last week. The scientific head of the US’s Operation Warp Speed, which is the program to supply America with vaccines, told US reporters the half-dose regime was only given to people aged 55 and below.
Scientists across the globe are expecting to find vaccines that run in older people. Older people are the group who are most at danger from Covid-19.
DHSC said the MHRA has already started a “rolling review” of the Oxford/AstraZeneca vaccine. Once the regulator receives the full safety, efficacy and quality data from the company, its scientists and clinicians “stand ready to progress its assessment of the vaccine “.
The Government stated it has secured access to 100 million doses of the Oxford/AstraZeneca jab and 40 million of the Pfizer/BioNTech vaccine. Mr Hancock also confirmed, if everything approved, a vaccine could be roll out from December.